Antimicrobial Prophylaxis and Preemptive Approaches for the Prevention of Infections in the Stem Cell Transplant Recipient, with Analogies to the Hematologic Malignancy Patient - 18/04/19
Résumé |
Infectious complications represent one of the most common causes of morbidity and mortality in allogeneic hematopoietic cell transplant (HCT) recipients. Prophylactic and preemptive treatment strategies against bacterial, fungal, viral, and parasitic pathogens are routinely implemented during high-risk post-HCT periods at most transplant centers. The basic concepts and review of current guidelines of antibiotic prophylaxis and empirical/preemptive antibiotic treatment in allogeneic HCT recipients are reviewed in this article.
Le texte complet de cet article est disponible en PDF.Keywords : Hematopoietic cell transplantation, Neutropenia, Antibiotic prophylaxis, Empirical treatment, Preemptive treatment, Antibiotics, Infectious complications
Plan
| Disclosure Statement: Dr D. Neofytos has served as a consultant for Gilead, MSD, Pfizer and Roche Diagnostics and has received research grants by MSD. |
Vol 33 - N° 2
P. 361-380 - juin 2019 Retour au numéro
Article précédent
- Complications of Stem Cell Transplantation that Affect Infections in Stem Cell Transplant Recipients, with Analogies to Patients with Hematologic Malignancies
- Sunita Nathan, Celalettin Ustun
- Work-up for Fever During Neutropenia for Both the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient
- Gowri Satyanarayana
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?